Breakdown | |||||
TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
199.15M | 173.98M | 159.24M | 142.41M | 93.58M | 105.04M | Gross Profit |
33.35M | 33.77M | 39.19M | 34.76M | 24.90M | 28.95M | EBIT |
-1.24M | -3.39M | -1.65M | 13.30M | 19.05M | 19.89M | EBITDA |
3.87M | 11.29M | 5.17M | 20.86M | 23.73M | 24.55M | Net Income Common Stockholders |
2.49M | 2.55M | -4.26M | 26.70M | 16.25M | 15.80M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
10.49M | 37.61M | 30.86M | 31.09M | 32.26M | 37.77M | Total Assets |
0.00 | 377.37M | 350.58M | 365.22M | 330.70M | 292.66M | Total Debt |
0.00 | 78.17M | 49.10M | 42.61M | 20.50M | 15.95M | Net Debt |
10.49M | 40.56M | 18.24M | 11.52M | -11.76M | -21.82M | Total Liabilities |
0.00 | 125.36M | 94.83M | 81.69M | 80.09M | 70.24M | Stockholders Equity |
134.61M | 228.43M | 230.85M | 253.06M | 228.00M | 199.19M |
Cash Flow | Free Cash Flow | ||||
0.00 | -27.17M | -10.38M | -28.46M | -9.23M | -26.43M | Operating Cash Flow |
0.00 | -16.06M | 5.63M | -10.91M | 4.03M | -7.34M | Investing Cash Flow |
0.00 | -7.14M | -15.64M | -9.84M | -10.87M | -11.36M | Financing Cash Flow |
0.00 | 30.23M | 10.38M | 19.36M | 249.00K | 3.26M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $94.87B | 18.05 | 42.85% | 6.91% | 1.35% | 4.06% | |
74 Outperform | $27.54B | 12.34 | 8.95% | 3.34% | -3.09% | 0.67% | |
68 Neutral | $71.05B | 629.07 | 0.21% | 2.92% | -11.90% | -97.93% | |
68 Neutral | $38.72B | 10.61 | 8.59% | 4.62% | 20.21% | 23.24% | |
66 Neutral | $412.93M | 4.72 | 4.82% | ― | 76.15% | 334.56% | |
64 Neutral | $8.66B | 14.63 | 4.98% | 174.64% | 3.54% | 3.46% |
Chia Tai Enterprises International Limited has announced that its board of directors will convene on May 15, 2025, to approve the unaudited financial results for the first quarter of 2025. This meeting is significant for stakeholders as it will provide insights into the company’s financial performance and strategic direction for the year.
Chia Tai Enterprises International Limited has announced its upcoming Annual General Meeting (AGM) to be held on June 10, 2025, in Hong Kong. The meeting will address several key agenda items, including the adoption of the company’s financial statements for 2024, the re-election of directors, and the re-appointment of KPMG as auditors. Additionally, the board seeks approval to issue new shares, which could potentially impact the company’s capital structure and shareholder value.
Chia Tai Enterprises International Limited has announced a revision of its annual caps for the years 2025 and 2026 under the 2023 Master HOEL Purchase Agreement due to a significant increase in sales to the HOEL Group. The company plans to increase the caps from the existing US$194.3 million and US$218.8 million to US$506.1 million and US$556.7 million respectively, reflecting anticipated growth in demand for its animal health products. This strategic move is expected to enhance the company’s market position and meet the expanding business needs of the HOEL Group, as well as accommodate potential increases in market prices and demand.
Chia Tai Enterprises International Limited has announced its annual financial results for the year ending December 31, 2024, reporting a substantial increase in revenue to US$307.7 million, up from US$173.9 million in 2023. The profit attributable to shareholders rose to US$11.2 million, reflecting a significant improvement in the company’s financial performance, though comprehensive income was affected by foreign exchange and investment impacts. Additionally, the company proposed the adoption of a new share option scheme to replace the existing one, which may impact the company’s stockholder strategy and employee incentives.